Gene therapy for neurological disorders: challenges and recent advancements
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene therapy for neurological disorders: challenges and recent advancements
Authors
Keywords
-
Journal
JOURNAL OF DRUG TARGETING
Volume -, Issue -, Pages 1-18
Publisher
Informa UK Limited
Online
2019-06-14
DOI
10.1080/1061186x.2019.1630415
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer’s Disease
- (2019) Bénédicte Foveau et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?
- (2018) Sudhanshu P. Raikwar et al. JOURNAL OF ALZHEIMERS DISEASE
- Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment
- (2018) Lakshmi Pallavi Ganipineni et al. JOURNAL OF CONTROLLED RELEASE
- MicroRNA-Regulated Gene Delivery Systems for Research and Therapeutic Purposes
- (2018) Bijay Dhungel et al. MOLECULES
- Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressiveSOD1ALS
- (2018) Michael Benatar et al. NEUROLOGY
- In vivo methods for acute modulation of gene expression in the central nervous system
- (2018) Andrzej W. Cwetsch et al. PROGRESS IN NEUROBIOLOGY
- Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease
- (2018) Valerie T. Y. Tan et al. Molecular Brain
- The Dynamic DNA Demethylation during Postnatal Neuronal Development and Neural Stem Cell Differentiation
- (2018) Huikang Tao et al. Stem Cells International
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update
- (2018) Hanley Abramson INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations
- (2018) Fani Memi et al. SEMINARS IN PERINATOLOGY
- Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
- (2018) Bryan G. Harder et al. Frontiers in Oncology
- Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond
- (2017) Paul N. Valdmanis et al. HUMAN GENE THERAPY
- Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen-induced retinopathy: beneficial effect of the absence of AQP4
- (2017) Francesco Pisani et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I
- (2017) Rachele Penati et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer’s Disease
- (2017) Mengqian Li et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery
- (2017) Chaitanya R. Joshi et al. Journal of Neuroimmune Pharmacology
- Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection
- (2017) Chandra M. Menendez et al. JOURNAL OF NEUROIMMUNOLOGY
- Fully human CD19-specific chimeric antigen receptors for T-cell therapy
- (2017) D Sommermeyer et al. LEUKEMIA
- Treatment of brain disease in the mucopolysaccharidoses
- (2017) Maurizio Scarpa et al. MOLECULAR GENETICS AND METABOLISM
- A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice
- (2017) Simone Merlin et al. MOLECULAR THERAPY
- Evolving Gene Therapy in Primary Immunodeficiency
- (2017) Adrian J. Thrasher et al. MOLECULAR THERAPY
- In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models
- (2017) Chaoran Yin et al. MOLECULAR THERAPY
- A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome
- (2017) Valerie Matagne et al. NEUROBIOLOGY OF DISEASE
- The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes
- (2017) Valentin K. Gribkoff et al. NEUROPHARMACOLOGY
- Viral vectors for therapy of neurologic diseases
- (2017) Sourav R. Choudhury et al. NEUROPHARMACOLOGY
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors
- (2017) Elena Herrera-Carrillo et al. Human Gene Therapy Methods
- Implications of MicroRNAs in Oncolytic Virotherapy
- (2017) Xavier Bofill-De Ros et al. Frontiers in Oncology
- Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4
- (2017) Sophie Grabar et al. PLoS One
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- An Optimized Protocol for Packaging Pseudotyped Integrase Defective Lentivirus
- (2016) Ranjita Sengupta et al. BIOLOGICAL PROCEDURES ONLINE
- Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma
- (2016) Tang Liu et al. CANCER LETTERS
- Alzheimer's disease: Targeting the Cholinergic System
- (2016) Talita H. Ferreira-Vieira et al. Current Neuropharmacology
- Current status of non-viral gene therapy for CNS disorders
- (2016) Rahul Dev Jayant et al. Expert Opinion on Drug Delivery
- Therapeutic rAAVrh10 MediatedSOD1Silencing in AdultSOD1G93AMice and Nonhuman Primates
- (2016) Florie Borel et al. HUMAN GENE THERAPY
- Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
- (2016) Michaël Hocquemiller et al. HUMAN GENE THERAPY
- Genome-editing technologies for gene correction of hemophilia
- (2016) Chul-Yong Park et al. HUMAN GENETICS
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
- (2016) Joana Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Origins of Programmable Nucleases for Genome Engineering
- (2016) Srinivasan Chandrasegaran et al. JOURNAL OF MOLECULAR BIOLOGY
- Current Progress in Therapeutic Gene Editing for Monogenic Diseases
- (2016) Versha Prakash et al. MOLECULAR THERAPY
- Engineered Viruses as Genome Editing Devices
- (2016) Xiaoyu Chen et al. MOLECULAR THERAPY
- Database Resources of the National Center for Biotechnology Information
- (2016) NUCLEIC ACIDS RESEARCH
- Brain-derived and glial cell line-derived neurotrophic factor fusion protein immobilization to laminin
- (2016) Baoxin Wang et al. Experimental and Therapeutic Medicine
- Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis
- (2016) Lorelei Stoica et al. Frontiers in Molecular Neuroscience
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Bacterial CRISPR: accomplishments and prospects
- (2015) Jason M Peters et al. CURRENT OPINION IN MICROBIOLOGY
- Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
- (2015) O. van Tellingen et al. DRUG RESISTANCE UPDATES
- Gene therapy for neurological disorders
- (2015) Chi-Jing Choong et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
- (2015) Jennifer L. Gori et al. HUMAN GENE THERAPY
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2015) Theo Vos et al. LANCET
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Diagnosis and Management of Autism Spectrum Disorder in the Era of Genomics
- (2015) Elizabeth Baker et al. PEDIATRIC CLINICS OF NORTH AMERICA
- In vivo RNAi screens: concepts and applications
- (2015) Shane Crotty et al. TRENDS IN IMMUNOLOGY
- Progresses towards safe and efficient gene therapy vectors
- (2015) Sergiu Chira et al. Oncotarget
- Genetics of Autism Spectrum Disorder: Current Status and Possible Clinical Applications
- (2015) Heejeong Yoo Experimental Neurobiology
- A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
- (2014) Michael S. Rafii et al. Alzheimers & Dementia
- MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
- (2014) M A Baertsch et al. CANCER GENE THERAPY
- Adenovirus: The First Effective In Vivo Gene Delivery Vector
- (2014) Ronald G. Crystal HUMAN GENE THERAPY
- Silencing Mutant Huntingtin by Adeno-Associated Virus-Mediated RNA Interference Ameliorates Disease Manifestations in the YAC128 Mouse Model of Huntington's Disease
- (2014) Lisa M. Stanek et al. HUMAN GENE THERAPY
- US population aging and demand for inpatient services
- (2014) Daniel J. Pallin et al. Journal of Hospital Medicine
- Delayed Disease Onset and Extended Survival in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis after Suppression of Mutant SOD1 in the Motor Cortex
- (2014) G. M. Thomsen et al. JOURNAL OF NEUROSCIENCE
- Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
- (2014) Robert E MacLaren et al. LANCET
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Huntingtin-lowering strategies in Huntington's disease: Antisense oligonucleotides, small RNAs, and gene editing
- (2014) Neil Aronin et al. MOVEMENT DISORDERS
- Regulation of microRNA biogenesis
- (2014) Minju Ha et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Huntington disease: natural history, biomarkers and prospects for therapeutics
- (2014) Christopher A. Ross et al. Nature Reviews Neurology
- Gene Therapy for the Nervous System: Challenges and New Strategies
- (2014) Casey A. Maguire et al. Neurotherapeutics
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
- (2014) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells
- (2014) Weicheng Yao et al. VIROLOGY
- Fragile X syndrome: From protein function to therapy
- (2013) Claudia Bagni et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Aquaporin and brain diseases
- (2013) Jérôme Badaut et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Development of gene therapy for blood disorders: an update
- (2013) A. W. Nienhuis BLOOD
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy
- (2013) F. Mingozzi et al. BLOOD
- The State of US Health, 1990-2010
- (2013) Christopher J. L. Murray JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer Gene Discovery: Exploiting Insertional Mutagenesis
- (2013) Marco Ranzani et al. MOLECULAR CANCER RESEARCH
- Overcoming Nonviral Gene Delivery Barriers: Perspective and Future
- (2013) Charles H. Jones et al. MOLECULAR PHARMACEUTICS
- Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s Disease
- (2013) Luis Quintino et al. MOLECULAR THERAPY
- Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy
- (2013) Raymond T Bartus et al. MOLECULAR THERAPY
- Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
- (2013) James N. Kochenderfer et al. Nature Reviews Clinical Oncology
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monetary Costs of Dementia in the United States
- (2013) Michael D. Hurd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease
- (2013) Carmela Giampà et al. PLoS One
- Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement
- (2013) A. V. Cideciyan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)
- (2013) Claire Géral et al. Pharmaceutics
- Inhibition of the NFAT Pathway Alleviates Amyloid Beta Neurotoxicity in a Mouse Model of Alzheimer's Disease
- (2012) E. Hudry et al. JOURNAL OF NEUROSCIENCE
- Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease
- (2012) J. L. Furman et al. JOURNAL OF NEUROSCIENCE
- TALENs: a widely applicable technology for targeted genome editing
- (2012) J. Keith Joung et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC
- (2012) Marc R Fabian et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Gene therapy and neurodevelopmental disorders
- (2012) Steven James Gray NEUROPHARMACOLOGY
- The Fast Changing Landscape of Sequencing Technologies and Their Impact on Microbial Genome Assemblies and Annotation
- (2012) Konstantinos Mavromatis et al. PLoS One
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Long-Term Follow-Up After Gene Therapy for Canavan Disease
- (2012) P. Leone et al. Science Translational Medicine
- Recent Advances in Nonviral Vectors for Gene Delivery
- (2011) Xia Guo et al. ACCOUNTS OF CHEMICAL RESEARCH
- Effects of Risperidone and Parent Training on Adaptive Functioning in Children With Pervasive Developmental Disorders and Serious Behavioral Problems
- (2011) Lawrence Scahill et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
- (2011) Steven J Gray et al. MOLECULAR THERAPY
- Construction of an Oncolytic Herpes Simplex Virus That Precisely Targets Hepatocellular Carcinoma Cells
- (2011) Xinping Fu et al. MOLECULAR THERAPY
- State-of-the-art gene-based therapies: the road ahead
- (2011) Mark A. Kay NATURE REVIEWS GENETICS
- Viral vectors for gene delivery to the central nervous system
- (2011) Thomas B. Lentz et al. NEUROBIOLOGY OF DISEASE
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy
- (2011) Kevin Scott Goudy et al. Frontiers in Microbiology
- BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease
- (2010) A Giralt et al. GENE THERAPY
- Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
- (2010) Elisa Dominguez et al. HUMAN MOLECULAR GENETICS
- Recent Advances in Lentiviral Vector Development and Applications
- (2010) Janka Mátrai et al. MOLECULAR THERAPY
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Late onset Alzheimer’s disease in older people
- (2010) Ahmet Turan Isik Clinical Interventions in Aging
- Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome
- (2009) Z Zeier et al. GENE THERAPY
- Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain
- (2009) Il-Doo Kim et al. JOURNAL OF CONTROLLED RELEASE
- Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane
- (2009) Alvaro Moreno-Aspitia et al. MAYO CLINIC PROCEEDINGS
- AAV1/2-mediated CNS Gene Delivery of Dominant-negative CCL2 Mutant Suppresses Gliosis, β-amyloidosis, and Learning Impairment of APP/PS1 Mice
- (2009) Tomomi Kiyota et al. MOLECULAR THERAPY
- Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
- (2009) Ryan L Boudreau et al. MOLECULAR THERAPY
- A Novel and Efficient Gene Transfer Strategy Reduces Glial Reactivity and Improves Neuronal Survival and Axonal Growth In Vitro
- (2009) Mathieu Desclaux et al. PLoS One
- Gene Therapy Using Adeno-Associated Virus Vectors
- (2008) S. Daya et al. CLINICAL MICROBIOLOGY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation